Bryan Jones serves as Executive at Aardvark Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Bryan Jones has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Oct 15, 2025 involved exercising options for 1,250 shares valued at $5.3K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Oct 15, 2025 | AARD | $5.3K | Option Exercise | 1,250 | $4.24 | Discretionary |
Bryan Jones currently holds 1,250 shares of Aardvark Therapeutics, Inc. (AARD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bryan Jones has been a net neutral trader of AARD stock. They have purchased $0 and sold $0 worth of shares.
Bryan Jones's most recent insider trade was on Oct 15, 2025, when they sold 1,250 shares at $4.24 per share.
Get notified when new Form 4 filings are submitted